Results 191 to 200 of about 162,220 (306)

A Case of Sjogren's Syndrome with Interstitial Lung Disease and Multiple Cystic Lung Disease [PDF]

open access: bronze, 2001
Dai Yong Jang   +6 more
openalex   +1 more source

Population Pharmacokinetics and Exposure‐Response Analysis of First‐Line Osimertinib Plus Chemotherapy in Patients with EGFR‐Mutated Advanced NSCLC

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Osimertinib, a third‐generation, central nervous system‐active epidermal growth factor receptor‐tyrosine kinase inhibitor, potently and selectively inhibits epidermal growth factor receptor‐tyrosine kinase inhibitor sensitizing and T790M resistance mutations, with efficacy in epidermal growth factor receptor‐mutated non‐small cell lung cancer.
Jincheng Yang   +10 more
wiley   +1 more source

Case Report: Osimertinib-induced acute interstitial lung disease. [PDF]

open access: yesFront Pharmacol
Lin Z   +5 more
europepmc   +1 more source

Experience With Nintedanib in Severe Pulmonary Fibrosis Associated With Systemic Sclerosis: A Case Series

open access: yesOpen Respiratory Archives, 2021
Jaume Bordas-Martinez   +8 more
doaj  

p53 and K-ras Expression in Interstitial Lung Disease [PDF]

open access: bronze, 2001
In‐Jae Oh   +9 more
openalex   +1 more source

Rodent monocyte‐derived macrophages do not express CD163: Comparative analysis using macrophages from living boreoeutherians

open access: yesDevelopmental Dynamics, EarlyView.
Abstract Background CD163 is a scavenger receptor predominantly expressed on the surfaces of macrophages in various mammalian species and is a marker of anti‐inflammatory (M2‐like) macrophages. High density of CD163‐positive tumor‐associated macrophages (TAMs) is associated with worse prognosis in various patient tumors.
Yoichi Saito   +9 more
wiley   +1 more source

Polyethylene flock-associated interstitial lung disease in a Spanish female [PDF]

open access: bronze, 2002
Encarnación Barroso   +3 more
openalex   +1 more source

Think highly of immunoglobulin G4‐related chronic rhinosinusitis as a clinical entity in immunoglobulin G4‐related disease

open access: yesEye &ENT Research, EarlyView.
Abstract IgG4‐related chronic rhinosinusitis (IgG4‐related CRS) is gaining recognition among various specialized physicians. As a systemic disease involving multiple organs, IgG4‐related CRS is still not widely recognized as an independent clinical entity. Given the complexity of diagnosing autoimmune‐related multisystem diseases, early recognition and
Lianqi Wan   +3 more
wiley   +1 more source

Interstitial Lung Disease and Risk of Lung Cancer.

open access: yesJAMA Netw Open
Xu H   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy